Spots Global Cancer Trial Database for A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Official Title: A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on the Head (Face or Scalp) Who Have Completed Day 57 in Studies PEP005-016 or PEP005-025 (REGION IIa and IIb)
Study ID: NCT00953732
Conditions
Interventions
Study Description
Brief Summary: This study is designed to follow up patients who have achieved complete clearance of AK lesions at the Day 57 visit having completed the PEP005-016 or PEP005-025 studies over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.
Detailed Description: A 12 month long-term follow-up study of patients who have achieved complete clearance of AK lesions at the Day 57 in the Phase 3 studies PEP005-016 or PEP005-025.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Burke Pharmaceutical Research, Hot Springs, Arizona, United States
Center for Dermatology, Fremont, California, United States
Dermatology Research Associates, Los Angeles, California, United States
Dermatology Specialists Inc, Oceanside, California, United States
Skin Surgery Medical Group Inc., San Diego, California, United States
Conant Medical Group, San Francisco, California, United States
North Florida Dermatology Associates, PA, Jacksonville, Florida, United States
University of Miami, Skin Research Camp, Miami, Florida, United States
Atlanta Dermatology, Vein & Research Center, LLC, Alpharetta, Georgia, United States
Medaphase Inc, Newnan, Georgia, United States
Altman Dermatology Associates, Arlington Heights, Illinois, United States
Glazer Dermatology, Buffalo Grove, Illinois, United States
Laser Skin Surgery Center of Indiana, Carmel, Indiana, United States
Deaconess Clinic, Inc, Evansville, Indiana, United States
Dawes Fretein Clinical Research Group, LLC, Indianapolis, Indiana, United States
The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Pedia Research LLC, Owensboro, Kentucky, United States
Hamzavi Dermatology, Fort Gratiot, Michigan, United States
Minnesota Clinical Study Center, Fridley, Minnesota, United States
Skin Specialists, PC, Omaha, Nebraska, United States
Karl G. Heine Dermatology, Henderson, Nevada, United States
Academic Dermatology Associates, Albuquerque, New Mexico, United States
Mount Sinai School of Medicine, New York, New York, United States
Dermatology Associates of Rochester, PC, Rochester, New York, United States
Dermatology, Laser Vein Specialists of the Carolinas, Charlotte, North Carolina, United States
Wake Research Associates, Raleigh, North Carolina, United States
Oregon Medical Research, Portland, Oregon, United States
Dermatology Research Associates, Nashville, Tennessee, United States
DermResearch, Inc., Austin, Texas, United States
J & S Studies, Inc., College Station, Texas, United States
Suzanne Bruce and Associates, The Center for Skin Research, Houston, Texas, United States
Progressive Clinical Research, San Antonio, Texas, United States
Dermatology Associates of Tyler, Tyler, Texas, United States
Center for Clinical Studies, Webster, Texas, United States
Dermatology Research Center, Inc., Salt Lake City, Utah, United States
The Education and Research Foundation, Lynchburg, Virginia, United States
Virginia Clinical Research, Inc, Norfolk, Virginia, United States
Premier Clinical Research, Spokane, Washington, United States
Southderm Pty Ltd, Kogarah, New South Wales, Australia
St George Dematology and Skin Cancer Centre, Kogarah, New South Wales, Australia
The Skin Centre, Benowa, Queensland, Australia
South East Dermatology, Belmont Specialist Centre, Carina Heights, Queensland, Australia
Contact Details
Name: Eugene Bauer, MD
Affiliation: Chief Medical Officer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
